Divis Labs gains from sales surge, Q4 net up 18%

The company had posted a net profit of Rs 196.43 crore in the corresponding period of the previous fiscal, Divis Laboratories said in a filing to BSE.

New Delhi: Drug firm Divis Laboratories on Saturday reported a 17.83 per cent rise in consolidated net profit at Rs 231.47 crore for the quarter ended March 2015, mainly due to robust sales.

The company had posted a net profit of Rs 196.43 crore in the corresponding period of the previous fiscal, Divis Laboratories said in a filing to BSE.

Consolidated total income from operations also rose to Rs 820.70 crore for the quarter under review against Rs 750.21 crore a year ago.

For the full year 2014-15, the consolidated net profit rose to Rs 851.52 crore, from Rs 773.34 crore in the year-ago period.

Consolidated total income from operations grew to Rs 3,114.94 crore in 2014-15, from Rs 2,532.14 crore in 2013-14.

In a separate filing to BSE, Divis Laboratories said its Board has recommended a dividend of 1,000 per cent, that is, Rs 20 per share of Rs 2 face value for the year ended March 2015.

By continuing to use the site, you agree to the use of cookies. You can find out more by clicking this link

Close